Community

The Robert Larner, M.D. College of Medicine at the University of Vermont has a remarkable community that provides ample opportunities to connect with fellow graduate students, postdocs, staff, and faculty. Offerings include workshops, conferences, events and seminars to bring together the perspectives of our diverse specialties. It is important to share your voice and feel heard as well as get involved with our Larner Community. 

Calendars of Events

Social Media Connections

SocialMedia.pexels-tracy-le-blanc-607812

UVM Handshake, UVM Connect, LinkedIn, Instagram, Twitter. . . find our social media communities by checking out these social media platforms here

Caporizzo Interviewed by WVNY about Research Findings on Promising New Heart Disease Treatment

August 12, 2024 by Lucy Gardner Carson

(AUGUST 12, 2024) Researchers including Matthew Caporizzo, Ph.D., assistant professor of molecular physiology and biophysics, have discovered a promising new treatment for heart disease, WVNY-TV reports.

Matthew Caporizzo, Ph.D., assistant professor of molecular physiology and biophysics at the University of Vermont’s Larner College of Medicine

(AUGUST 12, 2024) Researchers including Matthew Caporizzo, Ph.D., assistant professor of molecular physiology and biophysics at the University of Vermont’s Larner College of Medicine, and colleagues from the University of Pennsylvania’s Perelman School of Medicine have discovered a promising new treatment for heart disease, WVNY-TV reports.

Caporizzo says nearly 50 percent of those diagnosed with heart disease suffer from a condition that causes heart muscles to become plugged up. The new treatment is a vasohibin inhibitor, or VASHi, that allows those muscles to relax and get the heart to pump blood properly again.

“The primary symptom of this disease is exercise intolerance … This drug makes it so that relaxation helps the heart relax faster,” Caporizzo said. “Everything right now looks very promising … This is a really exciting thing because it does appear to work and it doesn’t appear to have a lot of harmful effects so far.”

The research, “Vasohibin inhibition improves myocardial relaxation in a rat model of heart failure with preserved ejection fraction,” was published in a recent issue of Science Translational Medicine.

Read full story at WVNY-TV